Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

2-5A antisense therapy directed against human telomerase RNA inhibits telomerase activity and induces apoptosis without telomere impairment in cervical cancer cells

Abstract

Human telomerase RNA (hTR), an important component of telomerase, is a possible target of telomerase-based cancer gene therapy. The present study was undertaken to assess the efficacy of antisense hTR therapy using newly developed 2-5A (5′-phosphorylated 2′-5′–linked oligoadenylate)–linked oligonucleotides against cervical cancer cells. ME180 and SiHa cells were treated with 2-5A–linked antisense hTR designed to complement the region of hTR between residues 76 and 94. The hTR expression, telomerase activity, cell viability, and apoptosis were then examined. The 2-5A anti-hTR effectively degraded hTR and inhibited telomerase activity. The 2-5A mutant anti-hTR and the anti-hTR without 2-5A were not capable of inhibiting telomerase activity. Inhibition of telomerase by 2-5A anti-hTR rapidly decreased cell viability only in telomerase-positive cells within 3–6 days after the treatment, when telomere length has not yet been shortened. This inhibition was associated with apoptosis, possibly through activation of caspase family members. These findings suggest that 2-5A–linked antisense-hTR therapy has a potent telomerase-inhibitory effect associated with a cytocidal effect from caspase-induced apoptosis, and may therefore be a potential tool in telomerase-based gene therapy against cervical cancers.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  1. Blackburn EH . Structure and function of telomeres Nature 1991 350: 569–573

    Article  CAS  Google Scholar 

  2. Watson JD . Origin of concatemeric T7 DNA Nature (London) New Biol 1972 239: 197–201

    Article  CAS  Google Scholar 

  3. Greider CW, Blackburn EH . A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis Nature 1989 337: 331–337

    Article  CAS  Google Scholar 

  4. Harley CB, Futcher BA, Greider CW . Telomeres shorten during aging of human fibroblast Nature 1990 345: 458–460

    Article  CAS  Google Scholar 

  5. Allsopp RC, Vaziri H, Patterson C . Telomere length predicts replicative capacity of human fibroblasts Proc Natl Acad Sci USA 1992 89: 10114–10118

    Article  CAS  Google Scholar 

  6. Counter CM, Avilion AA, LeFeuvre CE et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity EMBO J 1992 11: 1921–1929

    Article  CAS  Google Scholar 

  7. Kim NW, Piatyszek MA, Prowse KR et al. Specific association of human telomerase activity with immortal cells and cancer Science 1994 266: 2011–2015

    Article  CAS  Google Scholar 

  8. Feng J, Funk WD, Wang SS et al. The RNA component of human telomerase Science 1995 269: 1236–1241

    Article  CAS  Google Scholar 

  9. Harrington L, McPhail T, Mar V et al. A mammalian telomerase-associated protein Science 1997 275: 973–977

    Article  CAS  Google Scholar 

  10. Nakayama J, Saito M, Nakamura H, Matsuura A, Ishikawa F . TLP1: a gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family Cell 1997 88: 875–884

    Article  CAS  Google Scholar 

  11. Meyerson M, Counter CM, Eaton EN et al. HEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization Cell 1997 90: 785–795

    Article  CAS  Google Scholar 

  12. Nakamura TM, Morin GB, Chapman KB et al. Telomerase catalytic subunit homologs from fission yeast and human Science 1997 277: 955–959

    Article  CAS  Google Scholar 

  13. Liu Y, Snow BE, Hande MP et al. Telomerase-associated protein TEP1 is not essential for telomerase activity or telomere length maintenance in vivo Mol Cell Biol 2000 20: 8178–8184

    Article  CAS  Google Scholar 

  14. Bisoffi M, Chakerian AE, Fore ML et al. Inhibition of human telomerase by a retrovirus expressing telomeric antisense RNA Eur J Cancer 1998 34: 1242–1249

    Article  CAS  Google Scholar 

  15. Glukhov AI, Zimnik OV, Gordeev SA, Severin SE . Inhibition of telomerase activity of melanoma cells in vitro by antisense oligonucleotides Eur J Cancer 1998 34: 1242–1249

    Article  Google Scholar 

  16. Naka K, Yokozaki H, Yasui W, Tahara H, Tahara E, Tahara E . Effect of antisense human telomerase RNA transfection on the growth of human gastric cancer cell lines Biochem Biophys Res Commun 1999 255: 753–758

    Article  CAS  Google Scholar 

  17. Norton JC, Piatyszek MA, Wright WE, Shay JW, Corey DR . Inhibition of human telomerase activity by peptide nucleic acids Nat Biotechnol 1996 14: 615–619

    Article  CAS  Google Scholar 

  18. Pitts AE, Corey DR . Inhibition of human telomerase by 2′-O-methyl-RNA Proc Natl Acad Sci USA 1998 95: 11549–11554

    Article  CAS  Google Scholar 

  19. Torrence PF, Maitra RK, Lesiak K, Khamnei S, Zhou A, Silverman RH . Targeting RNA for degradation with a (2′-5′)oligoadenylate-antisense chimera Proc Natl Acad Sci USA 1993 90: 1300–1304

    Article  CAS  Google Scholar 

  20. Kyo S, Ueno H, Kanaya T, Inoue M . Telomerase activity in gynecological tumors Clin Cancer Res 1996 2: 2023–2028

    CAS  PubMed  Google Scholar 

  21. Takakura M, Kyo S, Kanaya T, Tanaka M, Inoue M . Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer Cancer Res 1998 58: 1558–1561

    CAS  PubMed  Google Scholar 

  22. Kondo S, Kondo Y, Li G, Silverman RH, Cowell JK . Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA Oncogene 1998 16: 3323–3330

    Article  CAS  Google Scholar 

  23. Wen J, Cong YS, Bacchetti S . Reconstitution of wild-type or mutant telomerase activity in telomerase-negative immortal human cells Hum Mol Genet 1998 7: 1137–1141

    Article  CAS  Google Scholar 

  24. Zhou A, Paranjape J, Brown TL et al. Interferon action and apoptosis are defective in mice devoid of 2′,5′-oligoadenylate–dependent RNase L EMBO J 1997 16: 6355–6363

    Article  CAS  Google Scholar 

  25. Kondo Y, Koga S, Komata T, Kondo S . Treatment of prostate cancer in vitro and in vivo with 2-5A anti-telomerase RNA component Oncogene 2000 19: 2205–2211

    Article  CAS  Google Scholar 

  26. Kushner DM, Paranjape JM, Bandyopadhyay B et al. 2-5A antisense directed against telomerase RNA produces apoptosis in ovarian cancer cells Gynecol Oncol 2000 76: 183–192

    Article  CAS  Google Scholar 

  27. Saretzki G, Ludwig A, von Zglinicki T, Runnebaum IB . Ribozyme-mediated telomerase inhibition induces immediate cell loss but not telomere shortening in ovarian cancer Cancer Gene Ther 2001 8: 827–834

    Article  CAS  Google Scholar 

  28. Ren JG, Xia HL, Tian YM, Just T, Cai GP, Dai YR . Expression of telomerase inhibits hydroxyl radical-induced apoptosis in normal telomerase negative human lung fibroblasts FEBS Lett 2001 Jan 19 488: 133–138

    Article  CAS  Google Scholar 

  29. Zhu H, Fu W, Mattson MP . The catalytic subunit of telomerase protects neurons against amyloid beta-peptide–induced apoptosis J Neurochem 2000 75: 117–124

    Article  CAS  Google Scholar 

  30. Fu W, Killen M, Culmsee C, Dhar S, Pandita TK, Mattson MP . The catalytic subunit of telomerase is expressed in developing brain neurons and serves a cell survival-promoting function J Mol Neurosci 2000 14: 3–15

    Article  CAS  Google Scholar 

  31. Holt SE, Glinsky VV, Ivanova AB, Glinsky GV . Resistance to apoptosis in human cells conferred by telomerase function and telomere stability Mol Carcinog 1999 25: 241–248

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported in part by a grant-in-aid for the Second-Term Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health and Welfare, Japan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Satoru Kyo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yatabe, N., Kyo, S., Kondo, S. et al. 2-5A antisense therapy directed against human telomerase RNA inhibits telomerase activity and induces apoptosis without telomere impairment in cervical cancer cells. Cancer Gene Ther 9, 624–630 (2002). https://doi.org/10.1038/sj.cgt.7700479

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.cgt.7700479

Keywords

This article is cited by

Search

Quick links